Eblasakimab | m-entrepreneurship.com

Product Name :
Eblasakimab

Search keywords :
Eblasakimab

drugId :
null

Target Vo:
Interleukin-13 receptor subunit alpha-1

Target Vo Short Name :
IL13RA1

Moa_Name:
Interleukin-13 receptor subunit alpha-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Csl Ltd

Active Company_Name :
ASLAN Pharmaceuticals Ltd

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:
Hypersensitivity

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IL-1 alpha Antibody Epigenetics
Zolbetuximab Formula
Iba1 Antibody: Iba1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to Iba1. It can be used for WB,IHC-P,FC,IP,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts